Read by QxMD icon Read


Franz G Wuertz, Ewald Kresnik, Philipp Malle, Martin Hyden, Peter Lind, Hermann Rogatsch, Hans J Gallowitsch
OBJECTIVE: To evaluate the diagnostic accuracy of a modified scrape cell block (SCB) technique in a large series of patients. The technique was especially developed and tested for fine-needle aspiration of thyroid and parathyroid nodules. STUDY DESIGN: Eighty-two ultrasound-guided fine-needle aspiration specimens with the sonographic aspect of a thyroid (n = 33) or a possible parathyroid nodule (n = 49) were studied. Immunohistochemistry (IHC) was used on cell blocks containing plasma, thromboplastin, and selected 3-dimensional cell aggregates scraped off Papanicolaou-stained smears...
2016: Acta Cytologica
Petra Konecnik Kresnik, Metka Krasna, Primoz Rozman, Bojan Vrtovec, Elvira Malicev
BACKGROUND: Mobilized peripheral blood is the most common source of CD34+ cells intended for transplantations. The collection and enrichment of CD34+ cells could be affected by various factors and there are some controversies regarding the effects of patient-related factors. The aim of this study was to assess the impact of age, sex, and diabetes on the CD34+ cell grafts in patients with chronic heart failure. STUDY DESIGN AND METHODS: Cell grafts from 100 adult patients scheduled for autologous CD34+ cell transplantation were investigated...
July 2016: Transfusion
E Kresnik, P Mikosch, H Gallowitsch, D Kogler, S Wieser, M Heinisch, O Unterweger, W Raunik, G Kumnig, I Gomez, G Grünbacher, P Lind
The aim of this study was to evaluate the usefulness of (18)F-FDG PET in the diagnosis and staging of primary and recurrent malignant head and neck tumours in comparison with conventional imaging methods [including ultrasonography, radiography, computed tomography (CT) and magnetic resonance imaging (MRI)], physical examination, panendoscopy and biopsies in clinical routine. A total of 54 patients (13 female, 41 male, age 61.3±12 years) were investigated retrospectively. Three groups were formed. In group I, (18)F-FDG PET was performed in 15 patients to detect unknown primary cancers...
July 2001: European Journal of Nuclear Medicine
G Sommer, M Schwarz, M Kutschera, R Kresnik, P Regitnig, A J Schriefl, H Wolinski, S D Kohlwein, G A Holzapfel
No abstract text is available yet for this article.
September 7, 2013: Biomedizinische Technik. Biomedical Engineering
S Kohlfürst, M Markitz, W Raunik, H E Eckel, E Kresnik, K Hausegger, M Salzwimmer, A Gaggl, F Chiari, P Lind
BACKGROUND: Today's available therapeutic options in head and neck cancer patients have led to better treatment modalities tailored to the individually clinical staging of the patients towards a risk adapted tumour management. This, however, is only possible with an accurately pretherapeutic diagnostic regimen and closely posttherapeutic follow-up. METHODS: These issues were discussed by nuclear medicine experts, otorhinolaryngologists, oral surgeons, radiologists, radio-oncologists and oncologists in a meeting that took place in Pörtschach, Austria, on 05 May 2006...
February 2009: Laryngo- Rhino- Otologie
P Mikosch, S Kohlfürst, H J Gallowitsch, E Kresnik, P Lind, A B Mehta, D A Hughes
Gaucher disease is the most prevalent inherited, lysosomal storage disease and is caused by deficient activity of the enzyme beta-glucocerebrosidase. Bone and bone marrow alterations are frequent in the most prevalent non-neuronopathic form of Gaucher disease. Imaging of bone manifestations in Gaucher disease is performed by a variety of imaging methods, conventional X-ray and MRI as the most frequently and most important ones. However, different modalities of scintigraphic imaging have also been used. This article gives an overview on scintigraphic imaging with respect to bone manifestations in Gaucher disease discussing the advantages and limitations of scintigraphic imaging in comparison to other imaging methods...
2008: Nuklearmedizin. Nuclear Medicine
Peter Mikosch, Katharina Kerschan-Schindl, Wolfgang Woloszczuk, Haro Stettner, Stefan Kudlacek, Ewald Kresnik, Hans J Gallowitsch, Peter Lind, Peter Pietschmann
BACKGROUND: Thyroid hormone administration is associated with low bone density in some studies. The aim of the present study was to evaluate the influence L-thyroxine, in doses used to treat patients with a history of thyroid carcinoma, on serum cathepsin K and other markers of bone metabolism. Cathepsin K is thought to have a role in osteoclast mediated bone resorption. METHODS: A group of male patients with differentiated thyroid cancer (DTC) on suppressive L-thyroxine therapy (DTC-group; n = 51; mean age 57 years; TSH < 0...
January 2008: Thyroid: Official Journal of the American Thyroid Association
I Igerc, S Kohlfürst, H J Gallowitsch, S Matschnig, E Kresnik, I Gomez-Segovia, P Lind
PURPOSE: Patients with persistent elevated PSA and repeated negative prostate biopsy, that means having the prostate biopsied at multiple times, were investigated with 18F-choline PET/CT to delineate prostate cancer and guide renewed prostate biopsy. METHODS: Twenty patients with elevated PSA and negative prostate biopsies underwent 18F-choline PET/CT. We performed an early examination of the pelvic region 3-5 min after application. After 30 minutes a whole body PET/CT examination was performed...
May 2008: European Journal of Nuclear Medicine and Molecular Imaging
H-J Gallowitsch, P Kraschl, I Igerc, T Hussein, E Kresnik, P Mikosch, S Kohlfuerst, K Hausegger, P Lind
UNLABELLED: The AIM of this study was to determine the additional value of SPECT/CT in sentinel node scintigraphy in breast cancer. Furthermore, it was our question to determine, whether the low-dose computed tomography component (LD-CT) can be used for axillary lymph node staging of clinically negative patients. PATIENTS, METHODS: 51 patients with invasive breast cancer <3 cm in diameter were included in our prospective investigation. SPECT/CT was performed on a dedicated scanner 30 minutes after subareolar injection of (99m)Tc-Nanocoll...
2007: Nuklearmedizin. Nuclear Medicine
Ante Skrobonja, Amir Muzur
Dr. Franjo (Franz) Kresnik (born Wien 1869 - died Rijeka 1943) was an excellent physician and a Central European intellectual, a bohemian mind whose two loves in life made him very special. His passions were medicine and violin making. Most of his life was spent in Susak (now a part of Rijeka, Croatia), where he worked, played music and studied the art of making stringed instruments. He visited Cremona on several occasions and studied a number of violins, drawings and tools made and used by old masters. For his profound knowledge of Cremonese violin making the Italians dubbed him "Uomo che legge violini" (The Man Who Can Read Violins)...
2007: Wiener Klinische Wochenschrift
Susanne Kohlfuerst, Isabel Igerc, Hans-Juergen Gallowitsch, Iris Gomez, Ewald Kresnik, Sabine Matschnig, Peter Lind
INTRODUCTION: The aim of our study was to determine whether treatment with a long-acting somatostatin-receptor analogue is effective in patients with (131)I-negative but somatostatin-receptor-positive metastases from dedifferentiated and anaplastic thyroid cancer. MATERIALS AND METHODS: Twelve patients were screened for the study. All of them showed progressive disease confirmed by radiologic evaluation, increasing serum thyroglobulin (Tg), and negative diagnostic or posttherapeutic (131)I whole-body scans (WBS)...
November 2006: Thyroid: Official Journal of the American Thyroid Association
Michael Zoller, Susanne Kohlfuerst, Isabel Igerc, Ewald Kresnik, Hans-Jürgen Gallowitsch, Iris Gomez, Peter Lind
PURPOSE: 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a well-established method in the follow-up of patients with differentiated thyroid carcinoma (DTC), elevated thyroglobulin (Tg) and negative 131I scans. This retrospective clinical study was designed to evaluate the impact of computed tomography (CT) and that of FDG-PET in combined FDG-PET/CT examinations on the restaging of DTC patients. METHODS: Forty-seven FDG-PET/CT scans of 33 patients with a history of DTC, elevated Tg levels and negative 131I uptake or additionally suspected 131I-negative lesions were studied...
April 2007: European Journal of Nuclear Medicine and Molecular Imaging
P Mikosch, I Igerc, S Kudlacek, W Woloszczuk, H J Gallowitsch, E Kresnik, H Stettner, G Grimm, P Lind, P Pietschmann
BACKGROUND: Suppressive thyroid hormone therapy is generally a lifelong treatment for patients with differentiated thyroid cancer (DTC). However, long-standing thyrotropin (TSH) suppression is a risk factor for osteoporosis. Osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) are central regulators of bone turnover. The aim was to analyze the effects of a suppressive thyroid hormone therapy in males with DTC on the OPG/RANKL system and on bone metabolism...
August 2006: European Journal of Clinical Investigation
I Gomez Segovia, H J Gallowitsch, E Kresnik, G Kumnig, I Igerc, S Matschnig, W J Stronegger, P Lind
INTRODUCTION: The aim of the study was to investigate the current thyroid carcinoma (TC) incidence in Carinthia, a former iodine-deficient, goiter-endemic region in Austria with approximately 550,000 inhabitants from 1984 to 2001. Using age-cohort analysis we analyzed the TC incidence under the impact of two regional risk factors: the contamination of Austrian soils by the radioactive fallout in from Chernobyl 1986 and the increased iodination of table salt in a general program of goiter prophylaxis begun in 1991...
April 2004: Thyroid: Official Journal of the American Thyroid Association
No abstract text is available yet for this article.
1951: Zdravstveni Vestnik
No abstract text is available yet for this article.
1951: Zdravstveni Vestnik
No abstract text is available yet for this article.
December 1950: Tuberkuloza
No abstract text is available yet for this article.
December 1950: Tuberkuloza
No abstract text is available yet for this article.
1950: Zdravstveni Vestnik
M Heinisch, H J Gallowitsch, P Mikosch, E Kresnik, G Kumnig, I Gomez, P Lind, H W Umschaden, J Gasser, E P Forsthuber
The aim of our study was a direct comparison of the ability of positron-emission tomography with FDG-PET and of magnetic resonance imaging (MRI) to determine whether breast lesions were benign or malignant and of the two imaging methods capability of depicting eventual multifocal disease. We performed both PET and MRI in 36 patients (40 lesions) who were scheduled for surgery because of suggestive mammographic, sonographic and/or clinical findings. A final histological classification was available for all lesions...
February 2003: Breast: Official Journal of the European Society of Mastology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"